Cited by 1,524Viral-associated cancers and disordersTransplantation: Methods and OutcomesRenal Transplantation Outcomes and Treatments

The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.

Spectrum of Cancer Risk Among US Solid Organ Transplant Recipients

Open access

Engels, Eric A., Pfeiffer, Ruth M., Fraumeni, Joseph F., Kasiske, Bertram L., Israni, Ajay K., Snyder, Jon J., Wolfe, Robert A., Goodrich, Nathan P., Bayakly, A. Rana, Clarke, Christina A., Copeland, Glenn, Finch, Jack L., Fleissner, Mary Lou, Goodman, Marc T., Kahn, Amy, Koch, Lori, Lynch, Charles F., Madeleine, Margaret M., Pawlish, Karen, Rao, Chandrika, Williams, Melanie A., Castenson, David, Curry, Michael, Parsons, Ruth, Fant, Gregory, Lin, Monica·2011·JAMA

DOI 10.1001/jama.2011.1592PMC PMC3310893

Open this paper in CoChat — free account

Abstract

CONTEXT: Solid organ transplant recipients have elevated cancer risk due to immunosuppression and oncogenic viral infections. Because most prior research has concerned kidney recipients, large studies that include recipients of differing organs can inform cancer etiology. OBJECTIVE: To describe the overall pattern of cancer following solid organ transplantation. DESIGN, SETTING, AND PARTICIPANTS: Cohort study using linked data on solid organ transplant recipients from the US Scientific Registry of Transplant Recipients (1987-2008) and 13 state and regional cancer registries. MAIN OUTCOME MEASURES: Standardized incidence ratios (SIRs) and excess absolute risks (EARs) assessing relative and absolute cancer risk in transplant recipients compared with the general population. RESULTS: The registry linkages yielded data on 175,732 solid organ transplants (58.4% for kidney, 21.6% for liver, 10.0% for heart, and 4.0% for lung). The overall cancer risk was elevated with 10,656 cases and an incidence of 1375 per 100,000 person-years (SIR, 2.10 [95% CI, 2.06-2.14]; EAR, 719.3 [95% CI, 693.3-745.6] per 100,000 person-years). Risk was increased for 32 different malignancies, some related to known infections (eg, anal cancer, Kaposi sarcoma) and others unrelated (eg, melanoma, thyroid and lip cancers). The most common malignancies with elevated risk were non-Hodgkin lymphoma (n = 1504; incidence: 194.0 per 100,000 person-years; SIR, 7.54 [95% CI, 7.17-7.93]; EAR, 168.3 [95% CI, 158.6-178.4] per 100,000 person-years) and cancers of the lung (n = 1344; incidence: 173.4 per 100,000 person-years; SIR, 1.97 [95% CI, 1.86-2.08]; EAR, 85.3 [95% CI, 76.2-94.8] per 100,000 person-years), liver (n = 930; incidence: 120.0 per 100,000 person-years; SIR, 11.56 [95% CI, 10.83-12.33]; EAR, 109.6 [95% CI, 102.0-117.6] per 100,000 person-years), and kidney (n = 752; incidence: 97.0 per 100,000 person-years; SIR, 4.65 [95% CI, 4.32-4.99]; EAR, 76.1 [95% CI, 69.3-83.3] per 100,000 person-years). Lung cancer risk was most elevated in lung recipients (SIR, 6.13 [95% CI, 5.18-7.21]) but also increased among other recipients (kidney: SIR, 1.46 [95% CI, 1.34-1.59]; liver: SIR, 1.95 [95% CI, 1.74-2.19]; and heart: SIR, 2.67 [95% CI, 2.40-2.95]). Liver cancer risk was elevated only among liver recipients (SIR, 43.83 [95% CI, 40.90-46.91]), who manifested exceptional risk in the first 6 months (SIR, 508.97 [95% CI, 474.16-545.66]) and a 2-fold excess risk for 10 to 15 years thereafter (SIR, 2.22 [95% CI, 1.57-3.04]). Among kidney recipients, kidney cancer risk was elevated (SIR, 6.66 [95% CI, 6.12-7.23]) and bimodal in onset time. Kidney cancer risk also was increased in liver recipients (SIR, 1.80 [95% CI, 1.40-2.29]) and heart recipients (SIR, 2.90 [95% CI, 2.32-3.59]). CONCLUSION: Compared with the general population, recipients of a kidney, liver, heart, or lung transplant have an increased risk for diverse infection-related and unrelated cancers.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1001/jama.2011.1592

Cites

43 of 43 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues
Swerdlow, S. H. (2017) · Medical Entomology and Zoology · Cited by 12,933
Preoperative assessment of liver function: a comparison of 99mTc‐Mebrofenin scintigraphy with indocyanine green clearance test
Erdogan, D., Heijnen, B. H. M., Bennink, R. J., Kok, M., Dinant, S., Straatsburg, I. H., Gouma, D. J., & van Gulik, T. M. (2004) · Liver International · doi:10.1111/j.1478-3231.2004.00901.x · Cited by 11,656
Liver Transplantation for the Treatment of Small Hepatocellular Carcinomas in Patients with Cirrhosis
Mazzaferro, V., Regalia, E., Doci, R., Andreola, S. A., Pulvirenti, A., Bozzetti, F., Montalto, F., Ammatuna, M., Morabito, A., & Gennari, L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603143341104 · Cited by 7,173
Acute Abdomen: A Rare Case of Ruptured Hepatocellular Carcinoma
Gloor, S., Jensen, K. O., Breitenstein, S., Binkert, C. A., Angst, E., & Hetzer, F. H. (2017) · Case Reports in Gastroenterology · doi:10.1159/000463378 · Cited by 5,370
Statistical Methods in Cancer Research. Volume II – The Design and Analysis of Cohort Studies
Juul, S. (1989) · Scandinavian Journal of Social Medicine · doi:10.1177/140349488901700214 · Cited by 3,602
A review of human carcinogens—Part B: biological agents
Bouvard, V., Baan, R., Straif, K., Grosse, Y., Secretan, B., Ghissassi, F. E., Benbrahim-Tallaa, L., Guha, N., Freeman, C., Galichet, L., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70096-8 · Cited by 2,935
Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis
Grulich, A. E., van Leeuwen, M. T., Falster, M. O., & Vajdic, C. M. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61050-2 · Cited by 2,321
Statistical methods in cancer research. Volume II--The design and analysis of cohort studies.
Breslow, N. E., & Day, N. E. (1987) · PubMed · Cited by 1,684
Overdiagnosis in Cancer
Welch, H. G., & Black, W. C. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq099 · Cited by 1,627
The design and analysis of cohort studies
Breslow, N. E., & Day, N. E. (1987) · International Agency for Research on Cancer eBooks · Cited by 1,312

Show all 43 references

Sorted by citations

Items 201–300 of 1,000

Effects of mTOR-Is on malignancy and survival following renal transplantation: A systematic review and meta-analysis of randomized trials with a minimum follow-up of 24 months
Wolf, S., Hoffmann, V. S., Habicht, A., Kauke, T., Bucher, J. N., Schoenberg, M. B., Werner, J., Guba, M. O., & Andrassy, J. (2018) · PLoS ONE · doi:10.1371/journal.pone.0194975 · Cited by 51
Risk of lung cancer in lung transplant recipients in the United States
Triplette, M., Crothers, K. A., Mahale, P. S., Yanik, E. L., Valapour, M., Lynch, C. F., Schabath, M. B., Castenson, D., & Engels, E. A. (2018) · American Journal of Transplantation · doi:10.1111/ajt.15181 · Cited by 51
Self-citation
Immunodeficiency-associated viral oncogenesis
Pierangeli, A., Antonelli, G., & Gentile, G. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.07.009 · Cited by 50
Effect of HIV on survival in patients with non-small-cell lung cancer in the era of highly active antiretroviral therapy: a population-based study
Rengan, R., Mitra, N., Liao, K., Armstrong, K., & Vachani, A. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70466-7 · Cited by 50
Oncologic Issues and Kidney Transplantation: A Review of Frequency, Mortality, and Screening
Asch, W. S., & BIA, M. J. (2013) · Advances in Chronic Kidney Disease · doi:10.1053/j.ackd.2013.07.003 · Cited by 49
Prevalence and outcome of lung cancer in lung transplant recipients
Grewal, A. S., Padera, R. F., Boukedes, S. S., Divo, M. J., Rosas, I. O., Camp, P. C., Fuhlbrigge, A. L., Goldberg, H. J., & El‐Chemaly, S. (2015) · Respiratory Medicine · doi:10.1016/j.rmed.2014.12.013 · Cited by 49
De novo cancer incidence after kidney and liver transplantation: Results from a nationwide population based data
Park, B., Yoon, J., Choi, D., Kim, H., Jung, Y. K., Kwon, O. J., & Lee, K. G. (2019) · Scientific Reports · doi:10.1038/s41598-019-53163-9 · Cited by 49
Malignancy after lung transplantation
Shtraichman, O., & Ahya, V. N. (2020) · Annals of Translational Medicine · doi:10.21037/atm.2020.02.126 · Cited by 48
Risk of diffuse large B‐cell lymphoma after solid organ transplantation in the United States
Gibson, T. M., Engels, E. A., Clarke, C. A., Lynch, C. F., Weisenburger, D. D., & Morton, L. M. (2014) · American Journal of Hematology · doi:10.1002/ajh.23726 · Cited by 48
Self-citation
De novo malignancy post–liver transplantation: a single center, population controlled study
Chatrath, H., Berman, K. H., Vuppalanchi, R., Slaven, J. E., Kwo, P. Y., Tector, A. J., Chalasani, N., & Ghabril, M. (2013) · Clinical Transplantation · doi:10.1111/ctr.12171 · Cited by 48
Pharmacokinetic models to assist the prescriber in choosing the best tacrolimus dose
Woillard, J., Saint‐Marcoux, F., Debord, J., & Åsberg, A. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.02.016 · Cited by 48
Survival after the diagnosis of de novo malignancy in liver transplant recipients
Taborelli, M., Piselli, P., Ettorre, G. M., Baccarani, U., Burra, P., Lauro, A., Galatioto, L., Rendina, M. G., Shalaby, S., Petrara, M. R., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31782 · Cited by 49
Incidence and Mortality of Renal Cell Carcinoma after Kidney Transplantation: A Meta-Analysis
Chewcharat, A., Thongprayoon, C., Bathini, T., Aeddula, N. R., Boonpheng, B., Kaewput, W., Watthanasuntorn, K., Lertjitbanjong, P., Sharma, K., Torres-Ortiz, A., et al. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8040530 · Cited by 48
Human papillomavirus‐related anogenital premalignancies and cancer in renal transplant recipients: A Danish nationwide, registry‐based cohort study
Reinholdt, K., Thomsen, L. T., Dehlendorff, C., Larsen, H. K., Sørensen, S. S., Hædersdal, M., & Kjær, S. K. (2019) · International Journal of Cancer · doi:10.1002/ijc.32565 · Cited by 48
Atopy and Specific Cancer Sites: a Review of Epidemiological Studies
Cui, Y., & Hill, A. W. (2016) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-016-8559-2 · Cited by 47
Incidence and Predictors of Cancer Following Kidney Transplantation in Childhood
Francis, A., Johnson, D. W., Craig, J. C., & Wong, G. (2017) · American Journal of Transplantation · doi:10.1111/ajt.14289 · Cited by 47
The case for BK polyomavirus as a cause of bladder cancer
Starrett, G. J., & Buck, C. B. (2019) · Current Opinion in Virology · doi:10.1016/j.coviro.2019.06.009 · Cited by 47
De Novo Malignancy After Heart, Kidney, and Liver Transplant: A Nationwide Study in Taiwan
Yeh, C.-C., Khan, A. B., Muo, C., Yang, H.-R., Li, P.-C., Chang, C.-H., Chen, T.-L., Jeng, L., & Liao, C. (2020) · Experimental and Clinical Transplantation · doi:10.6002/ect.2019.0210 · Cited by 47
Nonskeletal and skeletal effects of high doses versus low doses of vitamin D3 in renal transplant recipients: Results of the VITALE (VITamin D supplementation in renAL transplant recipients) study, a randomized clinical trial
Courbebaisse, M., Bourmaud, A., Souberbielle, J., Sberro‐Soussan, R., Moal, V., Meur, Y. L., Kamar, N., Albano, L., Thierry, A., Dantal, J., et al. (2023) · American Journal of Transplantation · doi:10.1016/j.ajt.2022.12.007 · Cited by 46
Food and Drug Administration ( FDA ) drug approval end points for chronic cutaneous ulcer studies
Eaglstein, W. H., Kirsner, R. S., & Robson, M. C. (2012) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2012.00849.x · Cited by 46
The etiologic spectrum of head and neck squamous cell carcinoma in young patients
Liu, X., Gao, X., Liang, X., & Tang, Y. (2016) · Oncotarget · doi:10.18632/oncotarget.11265 · Cited by 46
Natural Killer Cells: A Review of Biology, Therapeutic Potential and Challenges in Treatment of Solid Tumors
Choucair, K., Duff, J. R., Cassidy, C. S., Albrethsen, M., Kelso, J. D., Lenhard, A., Staats, H., Patel, R., Brunicardi, F. C., Dworkin, L. D., et al. (2019) · Future Oncology · doi:10.2217/fon-2019-0116 · Cited by 49
The prognostic significance of tumor-infiltrating lymphocytes assessment with hematoxylin and eosin sections in resected primary lung adenocarcinoma
Kim, A., Lee, S. J., Ahn, J., Park, W. Y., Shin, D., Lee, C. H., Kwon, H., Jeong, Y. J., Ahn, H. Y., Hoseok, I., et al. (2019) · PLoS ONE · doi:10.1371/journal.pone.0224430 · Cited by 48
The long-term risk of lymphoma and skin cancer did not increase after topical calcineurin inhibitor use and phototherapy in a cohort of 25,694 patients with vitiligo
Ju, H. J., Han, J. H., Kim, M., Lee, S., Shin, J.-W., Choi, M., Jeong, K., Han, T. Y., Choi, C. W., Lee, H. J., et al. (2021) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2021.01.067 · Cited by 46
Decreasing incidence of cancer after liver transplantation-A Nordic population-based study over 3 decades
Nordin, A., Åberg, F., Pukkala, E., Pedersen, C. R., Storm, H. H., Rasmussen, A., Bennet, W., Olausson, M., Wilczek, H., Ericzon, B.-G., et al. (2018) · American Journal of Transplantation · doi:10.1111/ajt.14507 · Cited by 45
Standardized Outcomes in Nephrology-Transplantation: A Global Initiative to Develop a Core Outcome Set for Trials in Kidney Transplantation
Tong, A., Budde, K., Gill, J., Josephson, M. A., Marson, L., Pruett, T. L., Reese, P. P., Rosenbloom, D., Rostaing, L. P. E., Warrens, A. Ν., et al. (2016) · Transplantation Direct · doi:10.1097/txd.0000000000000593 · Cited by 45
Cancer‐attributable mortality among solid organ transplant recipients in the United States: 1987 through 2014
Noone, A., Pfeiffer, R. M., Dorgan, J. F., Magder, L. S., Bromberg, J. S., Lynch, C. F., Morris, C. R., Pawlish, K. S., & Engels, E. A. (2019) · Cancer · doi:10.1002/cncr.32136 · Cited by 45
Self-citation
Birth of a Healthy Baby 9 Years After a Surgically Successful Deceased Donor Uterus Transplant
Ozkan, O., Ozkan, O., Dogan, N. U., Bahceci, M., Mendilcioglu, I., Boynukalin, K., Ongun, H., Kantarci, A. M., Yaprak, M., Cengiz, M., et al. (2021) · Annals of Surgery · doi:10.1097/sla.0000000000005346 · Cited by 45
Induction of APOBEC3-mediated genomic damage in urothelium implicates BK polyomavirus (BKPyV) as a hit-and-run driver for bladder cancer
Baker, S. C., Mason, A. S., Slip, R. G., Skinner, K. T., Macdonald, A., Masood, O., Harris, R. S., Fenton, T. R., Periyasamy, M., Ali, S., et al. (2022) · Oncogene · doi:10.1038/s41388-022-02235-8 · Cited by 45
More on Hepatocellular Carcinoma after the Fontan Procedure
Elder, R. W., Parekh, S., & Book, W. (2013) · New England Journal of Medicine · doi:10.1056/nejmc1306854 · Cited by 45
Presence of CD3-positive T-cells in oral premalignant leukoplakia indicates prevention of cancer transformation.
Öhman, J. N., Mowjood, R., Larsson, L., Kovács, A., Magnusson, B., Kjeller, G., Jontell, M., & Hasséus, B. (2015) · PubMed · Cited by 44
Orofacial diseases in solid organ and hematopoietic stem cell transplant recipients
Petti, S., Polimeni, A., Berloco, P., & Scully, C. M. (2012) · Oral Diseases · doi:10.1111/j.1601-0825.2012.01925.x · Cited by 44
Immunosuppression with mammalian target of rapamycin inhibitor and incidence of post-transplant cancer in kidney transplant recipients
Opelz, G., Unterrainer, C., Süsal, C., & Döhler, B. (2016) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfw088 · Cited by 44
Cancer risk in patients receiving renal replacement therapy: A meta-analysis of cohort studies
Shang, W., Huang, L., Li, L., Li, X., Zeng, R., Ge, S., & Xu, G. (2016) · Molecular and Clinical Oncology · doi:10.3892/mco.2016.952 · Cited by 44
RETRACTED: Increased Risk of Stomach and Esophageal Malignancies in People With AIDS
Persson, E. C., Shiels, M. S., Dawsey, S. M., Bhatia, K. G., Anderson, L. A., & Engels, E. A. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.07.013 · Cited by 44
Self-citation
Retracted
Improved keratinocyte carcinoma outcomes with annual dermatology assessment after solid organ transplantation: Population-based cohort study
Chan, A., Fung, K., Austin, P. C., Kim, S., Singer, L. G., Baxter, N. N., Alhusayen, R. O., & Rochon, P. A. (2018) · American Journal of Transplantation · doi:10.1111/ajt.14966 · Cited by 44
Cancer incidence and mortality after heart transplantation – A population-based national cohort study
Jäämaa‐Holmberg, S., Salmela, B., Lemström, K., Pukkala, ., & Lommi, J. (2019) · Acta Oncologica · doi:10.1080/0284186x.2019.1580385 · Cited by 44
Plasma Cell Neoplasms in US Solid Organ Transplant Recipients
Engels, E. A., Clarke, C. A., Pfeiffer, R. M., Lynch, C. F., Weisenburger, D. D., Gibson, T. M., Landgren, O., & Morton, L. M. (2013) · American Journal of Transplantation · doi:10.1111/ajt.12234 · Cited by 43
Self-citation
European Code against Cancer 4th Edition: Medical exposures, including hormone therapy, and cancer
Friis, S., Kesminiene, A., Espina, C., Auvinen, A. P., Straíf, K., & Schüz, J. (2015) · Cancer Epidemiology · doi:10.1016/j.canep.2015.08.003 · Cited by 45
Δ9-Tetrahydrocannabinol attenuates allogeneic host-versus-graft response and delays skin graft rejection through activation of cannabinoid receptor 1 and induction of myeloid-derived suppressor cells
Sido, J. M., Nagarkatti, P. S., & Nagarkatti, M. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.3a0115-030rr · Cited by 43
Research priority setting in organ transplantation: a systematic review
Tong, A., Sautenet, B., Chapman, J. R., Harper, C., Macdonald, P. S., Shackel, N. A., Crowe, S., Hanson, C. S., Hill, S., Synnot, A., et al. (2017) · Transplant International · doi:10.1111/tri.12924 · Cited by 43
Risk Factors for Melanoma in Renal Transplant Recipients
Ascha, M., Ascha, M. S., Tanenbaum, J., & Bordeaux, J. S. (2017) · JAMA Dermatology · doi:10.1001/jamadermatol.2017.2291 · Cited by 43
Risk of Rare Cancers Among Solid Organ Transplant Recipients
D’Arcy, M. E., Castenson, D., Lynch, C. F., Kahn, A. R., Morton, L. M., Shiels, M. S., Pfeiffer, R. M., & Engels, E. A. (2020) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djaa078 · Cited by 43
Self-citation
Donor-derived human herpesvirus 8 and development of Kaposi sarcoma among 6 recipients of organs from donors with high-risk sexual and substance use behavior
Dollard, S. C., Annambhotla, P. D., Wong, P., Meneses, K. G., Amin, M. M., Hoz, R. M. L., Lease, E. D., BUDEV, M. M., Arrossi, A. V., Basavaraju, S. V., et al. (2020) · American Journal of Transplantation · doi:10.1111/ajt.16181 · Cited by 43
Incidence and outcomes of primary central nervous system lymphoma in solid organ transplant recipients
Mahale, P. S., Shiels, M. S., Lynch, C. F., & Engels, E. A. (2017) · American Journal of Transplantation · doi:10.1111/ajt.14465 · Cited by 43
Self-citation
Spectrum of Nonkeratinocyte Skin Cancer Risk Among Solid Organ Transplant Recipients in the US
Sargen, M. R., Cahoon, E. K., Yu, K. J., Madeleine, M. M., Zeng, Y., Rees, J. R., Lynch, C. F., & Engels, E. A. (2022) · JAMA Dermatology · doi:10.1001/jamadermatol.2022.0036 · Cited by 43
Self-citation
Accelerated chronic skin changes without allograft vasculopathy: A 10-year outcome report after face transplantation
Kollár, B., Rizzo, N. M., Borges, T. J., Haug, V., Abdulrazzak, O., Kauke‐Navarro, M., Safi, A., Lian, C. G., Marty, F. M., Rutherford, A., et al. (2020) · Surgery · doi:10.1016/j.surg.2020.01.010 · Cited by 42
De Novo Malignancies After Organ Transplantation: Focus on Viral Infections
Piselli, P., Busnach, G., Fratino, L., Citterio, F., Ettorre, G. M., Paoli, P. D., & Serraino, D. (2013) · Current Molecular Medicine · doi:10.2174/15665240113139990041 · Cited by 42
Concomitant Simple Limbal Epithelial Transplantation After Surgical Excision of Ocular Surface Squamous Neoplasia
Kaliki, S., Mohammad, F. A., Tahiliani, P. S., & Sangwan, V. (2016) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2016.10.021 · Cited by 41
Honokiol inhibits c-Met-HO-1 tumor-promoting pathway and its cross-talk with calcineurin inhibitor-mediated renal cancer growth
Balan, M., Chakraborty, S., Flynn, E. A., Zurakowski, D., & Pal, S. (2017) · Scientific Reports · doi:10.1038/s41598-017-05455-1 · Cited by 41
Increasing incidence of melanoma after solid organ transplantation: a retrospective epidemiological study
Fattouh, K., Ducroux, E., Decullier, É., Kanitakis, J., Morélon, E., Boissonnat, P., Sebbag, L., Jullien, D., & Euvrard, S. (2017) · Transplant International · doi:10.1111/tri.13011 · Cited by 41
Non-immunological complications following kidney transplantation
Cohen‐Bucay, A., Gordon, C. E., & Francis, J. M. (2019) · F1000Research · doi:10.12688/f1000research.16627.1 · Cited by 43
Gynecologic cancers and solid organ transplantation
Liao, J. B., Fisher, C. E., & Madeleine, M. M. (2019) · American Journal of Transplantation · doi:10.1111/ajt.15292 · Cited by 41
Self-citation
Prostate Cancer Outcomes Following Solid-Organ Transplantation: A SEER-Medicare Analysis
Liauw, S. L., Ham, S. A., Das, L. C., Rudra, S., Packiam, V. T., Koshy, M., Weichselbaum, R. R., Becker, Y. T., Bodzin, A. S., & Eggener, S. E. (2019) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djz221 · Cited by 41
Donor or Recipient Origin of Posttransplant Lymphoproliferative Disorders Following Solid Organ Transplantation
Kinch, A., Cavelier, L. B., Bengtsson, M., Baecklund, E., Enblad, G., Backlin, C., Thunberg, U., Sundström, C., & Pauksens, K. (2014) · American Journal of Transplantation · doi:10.1111/ajt.12990 · Cited by 41
Malignancies: Pre and post transplantation strategies
AlBugami, M. M., & KIBERD, B. A. (2013) · Transplantation Reviews · doi:10.1016/j.trre.2013.12.002 · Cited by 40
Multicenter Experience With Robot-assisted Radical Prostatectomy in Renal Transplant Recipients
Polcari, A., Allen, J. C., Núñez-Nateras, R., Mmeje, C., Andrews, P. E., Milner, J., Castle, E. P., & Woods, M. E. (2012) · Urology · doi:10.1016/j.urology.2012.08.048 · Cited by 40
Acute Kidney Allograft Rejection Precipitated by Lenalidomide Treatment for Multiple Myeloma
Lum, E. L., Huang, E., Bunnapradist, S., Pham, T. N., & Danovitch, G. M. (2017) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2016.11.024 · Cited by 40
Voriconazole and the Risk of Keratinocyte Carcinomas Among Lung Transplant Recipients in the United States
D’Arcy, M. E., Pfeiffer, R. M., Rivera, D. R. R., Hess, G. P., Cahoon, E. K., Arron, S. T., Brownell, I., Cowen, E. W., Israni, A. K., Triplette, M., et al. (2020) · JAMA Dermatology · doi:10.1001/jamadermatol.2020.1141 · Cited by 41
Self-citation
Cancer immunoediting hypothesis: history, clinical implications and controversies
Lasek, W. (2022) · Central European Journal of Immunology · doi:10.5114/ceji.2022.117376 · Cited by 39
Conversion to everolimus dramatically improves the prognosis of de novo malignancies after liver transplantation for alcoholic liver disease
Thimonier, E., Guillaud, O., Walter, T., Decullier, É., Vallin, M., Boillot, O., & Dumortier, J. (2014) · Clinical Transplantation · doi:10.1111/ctr.12430 · Cited by 39
Islet Transplantation at the University of Alberta: Status Update and Review of Progress over the Last Decade
Senior, P. A., Kin, T., Shapiro, J., & Koh, A. (2012) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2012.01.002 · Cited by 42
Cancer immunotherapy in patients with preexisting autoimmune disorders
Donia, M., Pedersen, M., & Svane, I. M. (2016) · Seminars in Immunopathology · doi:10.1007/s00281-016-0595-8 · Cited by 39
Clinical outcomes of solid organ transplant recipients with metastatic cancers who are treated with immune checkpoint inhibitors: A single‐center analysis
Owoyemi, I. O., Vaughan, L. E., Costello, C. M., Thongprayoon, C., Markovic, S. N., Herrmann, J., Otley, C. C., Taner, T., Mangold, A. R., Leung, N., et al. (2020) · Cancer · doi:10.1002/cncr.33134 · Cited by 39
Infections after organ transplantation and immune response
Elalouf, A. (2023) · Transplant Immunology · doi:10.1016/j.trim.2023.101798 · Cited by 39
Cervical Cancer Screening in Immunocompromised Women
Nguyen, M. L., & Flowers, L. (2013) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2013.02.005 · Cited by 38
Comparison of Cancer Diagnoses Between the US Solid Organ Transplant Registry and Linked Central Cancer Registries
Yanik, E. L., Nogueira, L., Koch, L., Copeland, G. E., Lynch, C. F., Pawlish, K. S., Finch, J. L., Kahn, A. R., Hernandez, B. Y., Segev, D. L., et al. (2016) · American Journal of Transplantation · doi:10.1111/ajt.13818 · Cited by 38
Self-citation
Clinical and Genomic Characteristics of Small Cell Lung Cancer in Never Smokers
Thomas, A., Mian, I., Tlemsani, C., Pongor, L. S., Takahashi, N., Maignan, K., Snider, J. W., Li, G., Frampton, G. M., Ali, S. M., et al. (2020) · CHEST Journal · doi:10.1016/j.chest.2020.04.068 · Cited by 38
Typical and atypical properties of peripheral nerve allografts enable novel strategies to repair segmental-loss injuries
Bittner, G. D., Bushman, J. S., Ghergherehchi, C. L., Roballo, K. C. S., Shores, J. T., & Smith, T. A. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02395-0 · Cited by 37
British Society of Gastroenterology guidelines for diagnosis and management of autoimmune hepatitis
Gleeson, D. C., Bornand, R., Brownlee, A., Dhaliwal, H., Dyson, J. K., Hails, J., Henderson, P., Kelly, D. A., Mells, G. F., Miquel, R., et al. (2025) · Gut · doi:10.1136/gutjnl-2024-333171 · Cited by 44
Risk of Thyroid Cancer Among Solid Organ Transplant Recipients
Kitahara, C. M., Yanik, E. L., Ladenson, P. W., Hernandez, B. Y., Lynch, C. F., Pawlish, K. S., & Engels, E. A. (2017) · American Journal of Transplantation · doi:10.1111/ajt.14310 · Cited by 37
Self-citation
Risk of lip cancer after solid organ transplantation in the United States
Laprise, C., Cahoon, E. K., Lynch, C. F., Kahn, A. R., Copeland, G. E., Gonsalves, L., Madeleine, M. M., Pfeiffer, R. M., & Engels, E. A. (2018) · American Journal of Transplantation · doi:10.1111/ajt.15052 · Cited by 37
Self-citation
Impact of Pre-Transplant Malignancy on Outcomes After Kidney Transplantation: United Network for Organ Sharing Database Analysis
Livingston‐Rosanoff, D., Foley, D. P., LEVERSON, G. E., & Wilke, L. G. (2019) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2019.06.001 · Cited by 37
Treatments and outcomes for end-stage renal disease following Wilms tumor
Grigoriev, Y., Lange, J. M., Peterson, S., Takashima, J. R., Ritchey, M. L., Ko, D. S. C., Feusner, J. H., Shamberger, R. C., Green, D. M., & Breslow, N. E. (2012) · Pediatric Nephrology · doi:10.1007/s00467-012-2140-x · Cited by 37
State of the art: Cardiac transplantation
Davis, M. K., & Hunt, S. A. (2014) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2014.08.004 · Cited by 37
Higher Risk of Infections with PI3K–AKT–mTOR Pathway Inhibitors in Patients with Advanced Solid Tumors on Phase I Clinical Trials
Rafii, S., Roda, D., Geuna, E., Jiménez, B., Rihawi, K., Capelán, M., Yap, T. A., Molife, L. R., Kaye, S. B., Bono, J. S. D., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2424 · Cited by 38
Elevated Risk of Cancer After Solid Organ Transplant in Childhood: A Population-based Cohort Study
Kitchlu, A., Dixon, S. N., Dirk, J. S., Chanchlani, R., Vasilevska-Ristovska, J. Z., Borges, K., Dipchand, A. I., Ng, V. L., Hébert, D., Solomon, M. P., et al. (2018) · Transplantation · doi:10.1097/tp.0000000000002378 · Cited by 37
Skin cancer outcomes and risk factors in renal transplant recipients: Analysis of organ procurement and transplantation network data from 2000 to 2021
Hao, X., Lai, W., Xia, X., Xu, J., Wu, Y., Lv, C., Meng, Q., Lv, K., Huang, S., Luo, Z., et al. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1017498 · Cited by 36
An immunogenetic basis for lung cancer risk
Krishna, C., Tervi, A. M., Saffern, M., Wilson, E. A., Yoo, S., Mars, N., Roudko, V., Cho, B. A., Jones, S. E., Vaninov, N., et al. (2024) · Science · doi:10.1126/science.adi3808 · Cited by 42
Recent Advances in the Biology, Therapy and Management of Melanoma
Davids, L. M. (2013) · InTech eBooks · doi:10.5772/46052 · Cited by 38
Optimal oncologic management and mTOR inhibitor introduction are safe and improve survival in kidney and liver allograft recipients with de novo carcinoma
Rousseau, B., Guillemin, A., Duvoux, C., Neuzillet, C., Tlemsani, C., Compagnon, P., Azoulay, D., Salloum, C., Laurent, A., TAILLE, A. D. L., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31769 · Cited by 36
Sex differences in cancer risk and outcomes after kidney transplantation
Buxeda, A., Redondo‐Pachón, D., Pérez‐Sáez, M. J., Crespo, M., & Pascual, J. (2021) · Transplantation Reviews · doi:10.1016/j.trre.2021.100625 · Cited by 36
Cancer Cluster Investigations: Review of the Past and Proposals for the Future
Goodman, M. G., LaKind, J. S., Fagliano, J. A., Lash, T. L., Wiemels, J. L., Winn, D. M., Patel, C. J., Eenwyk, J. V., Kohler, B., Schisterman, E. F., et al. (2014) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph110201479 · Cited by 39
Self-citation
Long-term Kidney Transplant Survival Across the Globe
Hariharan, S., Rogers, N. M., Naesens, M., Pestana, J. M., Ferreira, G. F., Requião‐Moura, L., Foresto, R. D., Kim, S. J., Sullivan, K., Helanterä, I., et al. (2024) · Transplantation · doi:10.1097/tp.0000000000004977 · Cited by 35
Self-citation
Therapy-Related Myeloid Neoplasms: Complex Interactions among Cytotoxic Therapies, Genetic Factors, and Aberrant Microenvironment
Singhal, D., Kutyna, M., Hahn, C. N., Shah, M. V., & Hiwase, D. (2024) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-24-0103 · Cited by 39
Burkitt lymphoma risk in U.S. solid organ transplant recipients
Mbulaiteye, S. M., Clarke, C. A., Morton, L. M., Gibson, T. M., Pawlish, K. S., Weisenburger, D. D., Lynch, C. F., Goodman, M. T., & Engels, E. A. (2012) · American Journal of Hematology · doi:10.1002/ajh.23385 · Cited by 35
Self-citation
Risk Factors for Melanoma Among Survivors of Non-Hodgkin Lymphoma
Lam, C. J. K., Curtis, R. E., Dores, G. M., Engels, E. A., Caporaso, N. E., Polliack, A., Warren, J. L., Young, H. A., Levine, P. H., Elmi, A. F., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.60.2094 · Cited by 35
Self-citation
Risk Factors for De Novo Malignancy Following Lung Transplantation
Magruder, J. T., Crawford, T. C., Grimm, J. C., Kim, B., Shah, A. S., Bush, E. L., Higgins, R. S. D., & Merlo, C. A. (2016) · American Journal of Transplantation · doi:10.1111/ajt.13925 · Cited by 35
Sun exposure may increase risk of prostate cancer in the high UV environment of New South Wales, Australia: A case–control study
Nair‐Shalliker, V., Smith, D. P., Egger, S. J., Hughes, A. M., Kaldor, J. M., Clements, M., Kricker, A., & Armstrong, B. K. (2011) · International Journal of Cancer · doi:10.1002/ijc.27400 · Cited by 35
Major Histocompatibility Complex Class II HLA-DRα Is Downregulated by Kaposi's Sarcoma-Associated Herpesvirus-Encoded Lytic Transactivator RTA and MARCH8
Sun, Z., Jha, H. C., Pei, Y., & Robertson, E. S. (2016) · Journal of Virology · doi:10.1128/jvi.01079-16 · Cited by 35
Guanylate cyclase C as a target for prevention, detection, and therapy in colorectal cancer
Aka, A. A., Rappaport, J. A., Pattison, A. M., Sato, T., Snook, A. E., & Waldman, S. A. (2017) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2017.1292124 · Cited by 35
Impact of antiviral prophylaxis in adults Epstein-Barr Virus-seronegative kidney recipients on early and late post-transplantation lymphoproliferative disorder onset: a retrospective cohort study
Ville, S., Imbert‐Marcille, B., Coste‐Burel, M., Garandeau, C., Meurette, A., Cantarovich, D., Giral, M., Hourmant, M., Blancho, G., & Dantal, J. (2017) · Transplant International · doi:10.1111/tri.13085 · Cited by 35
Outcomes of Solid Organ Transplant Recipients With Advanced Cancers Receiving Immune Checkpoint Inhibitors
Saleem, N., Wang, J., Rejuso, A., Teixeira-Pinto, A. M., Stephens, J. H., Wilson, A. M., Kieu, A., Gately, R., Boroumand, F., Chung, E. Y. M., et al. (2025) · JAMA Oncology · doi:10.1001/jamaoncol.2025.2374 · Cited by 34
Cyclosporine A and tacrolimus inhibit urothelial tumorigenesis
Kawahara, T., Kashiwagi, E., Li, Y., Zheng, Y., Miyamoto, Y., Netto, G. J., Ishiguro, H., & Miyamoto, H. (2015) · Molecular Carcinogenesis · doi:10.1002/mc.22265 · Cited by 34
Lung cancer following lung transplant: Single institution 10 year experience
Belli, E., Landolfo, K. P., Keller, C. A., Thomas, M., & Odell, J. (2013) · Lung Cancer · doi:10.1016/j.lungcan.2013.05.018 · Cited by 34
Immune Checkpoint Inhibitors in Transplantation—A Case Series and Comprehensive Review of Current Knowledge
Delyon, J., Zuber, J., Dorent, R., Poujol‐Robert, A., Péraldi, M., Anglicheau, D., & Lebbé, C. (2020) · Transplantation · doi:10.1097/tp.0000000000003292 · Cited by 34
Racial/Ethnic Differences in Cancer Risk After Kidney Transplantation
Hall, E. C., Segev, D. L., & Engels, E. A. (2013) · American Journal of Transplantation · doi:10.1111/ajt.12066 · Cited by 34
Self-citation
Malignancies after pediatric kidney transplantation: more than PTLD?
Mynarek, M., Hussein, K., Kreipe, H. H., & Maecker‐Kolhoff, B. (2013) · Pediatric Nephrology · doi:10.1007/s00467-013-2622-5 · Cited by 35
Donor transmitted andde novocancer after liver transplantation
Desai, R. R. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i20.6170 · Cited by 34
Immunosuppressant-Driven De Novo Malignant Neoplasms after Solid-Organ Transplant
Billups, K. L., Neal, J. M., & Salyer, J. (2015) · Progress in Transplantation · doi:10.7182/pit2015826 · Cited by 34

Authors: Engels, E. A., Pfeiffer, R. M., Fraumeni, J. F., Kasiske, B. L., Israni, A. K., Snyder, J. J., Wolfe, R. A., Goodrich, N. P., Bayakly, A. R., Clarke, C. A., Copeland, G., Finch, J. L., Fleissner, M. L., Goodman, M. T., Kahn, A., Koch, L., Lynch, C. F., Madeleine, M. M., Pawlish, K., Rao, C., Williams, M. A., Castenson, D., Curry, M., Parsons, R., Fant, G., & Lin, M.
Affiliations: National Institutes of Health (US)
Arbor Research Collaborative for Health (US)
Cancer Prevention Institute of California (US)
Michigan Department of Health and Human Services (US)
Connecticut Agricultural Experiment Station (US)
University of Hawaiʻi at Mānoa (US)
Illinois Department of Public Health (US)
University of Iowa (US)
Fred Hutch Cancer Center (US)
New Jersey Department of Health (US)
Texas Department of State Health Services (US)
Information Management Services (US)
United States Department of Health and Human Services (US)
Corresponding author: Engels, Eric A.
ORCID: Engels, Eric A.
Pfeiffer, Ruth M.
Kasiske, Bertram L.
Israni, Ajay K.
Snyder, Jon J.
Goodrich, Nathan P.
Clarke, Christina A.
Copeland, Glenn
Finch, Jack L.
Goodman, Marc T.
Kahn, Amy
Lynch, Charles F.
Madeleine, Margaret M.
Pawlish, Karen
Rao, Chandrika
Castenson, David
Curry, Michael
Fant, Gregory
Venue: JAMA
Publisher: American Medical Association (AMA)
Published: 2011-11-02
Volume: 306
Issue: 17
Pages: 1891
ISSN: 0002-9955 (ISSN-L)
0098-7484
DOI: 10.1001/jama.2011.1592
PMC: PMC3310893
OpenAlex: W1964106115
Cited by: 1,524
References: 43
Citations by year: 2026: 83 · 2025: 100 · 2024: 100 · 2023: 89 · 2022: 106 · 2021: 114 · 2020: 134 · 2019: 124 · 2018: 107 · 2017: 114 · 2016: 108 · 2015: 106 · 2014: 97 · 2013: 83 · 2012: 55
FWCI: 37.37
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: JAMA (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Institutes of Health (n01pc54405-9-0-0, n01pc35143-20-0-1, n01pc35139-25-0-11, n01pc35142-19-0-0, n01pc35137-18-0-2)
National Cancer Institute (N01PC35139, HHSN261201000034 C, HHSN261201000036C, HHSN261201000035C, N01‐PC035137, N01 PC035143, N01 PC35142, HHSN261201000037C, N01-PC-54405, HHSN261201000035I, N01-PC-35 137, N01PC-35143, N01 PC035139, HHSN261201000024C, N01 PC035142, N01 PC054405, ZIACP010150)
National Center for Chronic Disease Prevention and Health Promotion (5U58DP000824-04, 5U58DP000812-03, U58 DP000812, U58 DP000817, U58 DP000805, U58 DP000807, U58 DP000848-04, U58 DP000832, 5U58DP000817-05, U58 DP000824, U58/DP000808, #1U58DP000807-01, 5658DP 000805-04, U58 DP000848, 5U58/DP000808-03)
Topics: Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
Health Sciences › Medicine › Transplantation › Renal Transplantation Outcomes and Treatments
Keywords: solid organ transplant recipients, cancer risk, immunosuppression, non-Hodgkin lymphoma, lung cancer, Kaposi's sarcoma, anal cancer, melanoma, thyroid cancer, lip cancer, hepatitis C, cytomegalovirus, Epstein-Barr virus, post-transplant lymphoproliferative disorder
MeSH terms: Adolescent, Adult, Aged, Child, Child, Preschool, Female, Humans, Immune Tolerance, Infant, Male, Middle Aged, Neoplasms, Registries, Risk, United States, Cohort Studies, Incidence, Organ Transplantation, Immunocompromised Host, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Spectrum of Cancer Risk Among US Solid Organ Transplant Recipients

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks